Aurobindo Pharma
BSE: 524804|NSE: AUROPHARMA|ISIN: INE406A01037|SECTOR: Pharmaceuticals
LIVE
BSE
May 25, 17:00
116.80
1.45 (1.26%)VOLUME 205,295
LIVE
NSE
May 25, 17:00
117.00
1.55 (1.34%) VOLUME 1,426,588
Half Yearly Results of Aurobindo Pharma |
------------------- in Rs. Cr. ------------------- |
| Sep '11 | Mar '11 | Sep '10 | Mar '10 | Sep '09 | ||||||
 | ||||||||||
|
||||||||||
| 6 mths | 6 mths | 6 mths | 6 mths | 6 mths | ||||||
|
||||||||||
| Sales Turnover | 1,987.83 | 2,215.18 | 1,917.94 | 1,662.99 | 1,589.28 | |||||
| Other Income | 3.45 | 4.08 | 3.91 | 96.14 | 12.25 | |||||
| Total Income | 1,991.28 | 2,219.26 | 1,921.85 | 1,759.13 | 1,601.53 | |||||
| Total Expenses | 1,857.78 | 1,696.74 | 1,479.18 | 1,289.18 | 1,213.53 | |||||
| Operating Profit | 130.05 | 518.44 | 438.76 | 373.81 | 375.75 | |||||
| Profit On Sale Of Assets | -- | -- | -- | -- | -- | |||||
| Profit On Sale Of Investments | -- | -- | -- | -- | -- | |||||
| Gain/Loss On Foreign Exchange | -- | -- | -- | -- | -- | |||||
| VRS Adjustment | -- | -- | -- | -- | -- | |||||
| Other Extraordinary Income/Expenses | -- | -- | -- | -- | -- | |||||
| Total Extraordinary Income/Expenses | -319.86 | -2.70 | 18.49 | -31.39 | 33.58 | |||||
| Tax On Extraordinary Items | -- | -- | -- | -- | -- | |||||
| Net Extra Ordinary Income/Expenses | -- | -- | -- | -- | -- | |||||
| Gross Profit | 133.50 | 522.52 | 442.67 | 469.95 | 388.00 | |||||
| Interest | 30.47 | 25.69 | 24.80 | 21.08 | 31.25 | |||||
| PBDT | -216.83 | 494.13 | 436.36 | 417.48 | 390.33 | |||||
| Depreciation | 68.55 | 66.20 | 58.84 | 50.00 | 45.46 | |||||
| Depreciation On Revaluation Of Assets | -- | -- | -- | -- | -- | |||||
| PBT | -285.38 | 427.93 | 377.52 | 367.48 | 344.87 | |||||
| Tax | -141.92 | 111.50 | 100.15 | 96.12 | 90.47 | |||||
| Net Profit | -143.46 | 316.43 | 277.37 | 271.36 | 254.40 | |||||
| Prior Year Income/Expenses | -- | -- | -- | -- | -- | |||||
| Depreciation for Previous Years Written Back/ Provided | -- | -- | -- | -- | -- | |||||
| Dividend | -- | -- | -- | -- | -- | |||||
| Dividend Tax | -- | -- | -- | -- | -- | |||||
| Dividend (%) | -- | -- | -- | -- | -- | |||||
| Earnings Per Share(Rs) | -- | 54.35 | 47.64 | 48.69 | 47.32 | |||||
| Book Value(Rs) | -- | -- | -- | -- | -- | |||||
| Equity | 29.11 | 29.11 | 29.11 | 27.86 | 26.88 | |||||
| Reserves | -- | 2,540.50 | -- | 1,886.51 | -- | |||||
| Face Value(Rs) | 1.00 | 5.00 | 5.00 | 5.00 | 5.00 | |||||
| ||||||||||
| Source : Dion Global Solutions Limited | ||||||||||
| ||||||||||
Results of Aurobindo Pharm
- News
- Results
- Estimates
- Analysis
Results of Pharmaceuticals Sector
- News
- Results
- Estimates
- Analysis
Quick Links for aurobindopharma
Related Searches
aurobindopharma Stock Price, Aurobindo%20Pharm Stock Quote, Aurobindo%20Pharm Results , Aurobindo%20Pharm News ..
More »
Follow moneycontrol.com
Explore Moneycontrol
Mutual Funds
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
News |
Markets |
IPO |
Technicals |
Mutual Fund |
Commodities |
Best Portfolio Manager |
Bse Sensex |
Bombay Stock Exchange |
Share Market Live |
Recession 2011 |
Commodities Price |
Silver Price/Rate in India |
Gold Price/Rate in India |
Crude Oil |
USD to INR |
National Stock Exchange |
Bank Fixed Deposits |
Company Fixed Deposits |
Small Savings Schemes |
Property rates in India |
Rss Feeds | Budget:2008, 2009, 2010, 2011, 2012 |
Intuit Money Manager |
RBI Credit Policy | BSE A Group Companies | BSE B Group Stocks | Union Budget
| Financial Glossary
|
Message Board |
Moneybhai |
Connect.in.com |
Business Yellow Pages |
India's Premiere Technology Guide |
History India | Davos
| Jet Airways | Air India | Bharti Airtel | BSE Sensex | Indira Gandhi International Airport | Petrol price | Reliance Power | Essar Group | Veerappa Moily | Mamata Banerjee
Site Map | About Us | Contact Us | Advertise | Bookmark | Disclaimer | Privacy Statement | Terms of Use | Careers
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.